Back to company

FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS: Financial statements 2024

CVR: 31586569

FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS (CVR 31586569) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -230,705 and a net result of DKK -191,005 compared with DKK -224,027 the year before. Equity amounted to DKK 3,254,686,944. The solvency ratio was 98.2%.

Gross Profit
-230,705 kr.
Profit/Loss
-191,005 kr.
Equity
3,254,686,944 kr.
Total Assets
3,312,863,513 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--231 t.-191 t.3.3 mia.-
2023--318 t.-224 t.3.3 mia.-
20220-204 t.-325 t.3.3 mia.-
2021--183 t.-155 t.3.3 mia.-
2018--29 t.-23.4 mio.425.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS

FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2008. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named BIOGEN (DENMARK) NEW MANUFACTURING ApS and BIOGEN IDEC (DENMARK) NEW MANUFACTURING ApS. The management consists of Lars Petersen. The company is owned by FUJIFILM Corporation. In 2025, the company reported a gross profit of DKK -242,387 and a net result of DKK -205,233 compared with DKK -191,005 the year before. Equity amounted to DKK 3,254,481,711.